New insights into the function of melatonin and its role in metabolic disturbances

References

• Cipolla-Neto J, do Amaral FG. Melatonin as a Hormone: new Physiological and Clinical Insights. Endocr Rev. 2018;39(6):990–1028.
   PubMed Web of Science ®Google Scholar
• Zhao D, Yu Y, Shen Y, et al. Melatonin Synthesis and Function: evolutionaryHistory in Animals and Plants [Review]. Front Endocrinol (Lausanne). 2019;10.
   Web of Science ®Google Scholar
• Tan DX, Hardeland R, Manchester LC, et al. The changing biological roles of melatonin during evolution: from an antioxidant to signals of darkness, sexual selection and fitness. Biol Rev Camb Philos Soc. 2010;85(3):607–623.
   PubMed Web of Science ®Google Scholar
• Tan DX, Reiter RJ. Mitochondria: the birth place, battle ground and the site of melatonin metabolism in cells [Review]. Melatonin Res. 2019;2(1):44–66.
   Google Scholar
• Acuna-Castroviejo D, Escames G, Venegas C, et al. Extrapineal melatonin: sources, regulation, and potential functions. Cell Mol Life Sci. 2014;71(16):2997–3025.
   PubMed Web of Science ®Google Scholar
• Erlich SS, Apuzzo ML. The pineal gland: anatomy, physiology, and clinical significance. J Neurosurg. 1985;63(3):321–341.
   PubMed Web of Science ®Google Scholar
• Cipolla-Neto J, Amaral FG, Afeche SC, et al. Melatonin, energy metabolism, and obesity: a review. J Pineal Res. 2014;56(4):371–381.
   PubMed Web of Science ®Google Scholar
• Klein DC, Weller JL. Indole metabolism in the pineal gland: a circadian rhythm in N-acetyltransferase. Science. 1970;169(3950):1093–1095.
   PubMed Web of Science ®Google Scholar
• Rath MF, Coon SL, Amaral FG, et al. Melatonin Synthesis: acetylserotonin O-Methyltransferase (ASMT) Is Strongly Expressed in a Subpopulation of Pinealocytes in the Male Rat Pineal Gland. Endocrinology. 2016;157(5):2028–2040.
   PubMed Web of Science ®Google Scholar
• Moller M, Baeres FM. The anatomy and innervation of the mammalian pineal gland. Cell Tissue Res. 2002;309(1):139–150.
   PubMed Web of Science ®Google Scholar
• Klein DC. Photoneural regulation of the mammalian pineal gland. Ciba Found Symp. 1985;117:38–56.
   PubMedGoogle Scholar
• Canteras NS, Ribeiro-Barbosa ER, Goto M, et al. The retinohypothalamic tract: comparison of axonal projection patterns from four major targets. Brain Res Rev. 2011;65(2):150–183.
   PubMedGoogle Scholar
• Alonso-Vale MI, Andreotti S, Mukai PY, et al. Melatonin and the circadian entrainment of metabolic and hormonal activities in primary isolated adipocytes. J Pineal Res. 2008;45(4):422–429.
   PubMed Web of Science ®Google Scholar
• Bartness TJ, Powers JB, Hastings MH, et al. The timed infusion paradigm for melatonin delivery: what has it taught us about the melatonin signal, its reception, and the photoperiodic control of seasonal responses? J Pineal Res. 1993;15(4):161–190.
   PubMed Web of Science ®Google Scholar
• Goldman BD. Mammalian photoperiodic system: formal properties and neuroendocrine mechanisms of photoperiodic time measurement. J Biol Rhythms. 2001;16(4):283–301.
   PubMed Web of Science ®Google Scholar
• Benitez-King G, Rios A, Martinez A, et al. In vitro inhibition of Ca2+/calmodulin-dependent kinase II activity by melatonin. Biochim Biophys Acta. 1996;1290(2):191–196.
   PubMed Web of Science ®Google Scholar
• Steinhilber D, Brungs M, Werz O, et al. The nuclear receptor for melatonin represses 5-lipoxygenase gene expression in human B lymphocytes. J Biol Chem. 1995;270(13):7037–7040.
   PubMed Web of Science ®Google Scholar
• Guerrero JM, Pozo D, Garcia-Maurino S, et al. Nuclear receptors are involved in the enhanced IL-6 production by melatonin in U937 cells. Biol Signals Recept. 2000;9(3–4):197–202.
   PubMedGoogle Scholar
• Amaral FGD, Cipolla-Neto J. A brief review about melatonin, a pineal hormone. Arch Endocrinol Metab. 2018;62(4):472–479.
   PubMed Web of Science ®Google Scholar
• Hazlerigg DG, Gonzalez-Brito A, Lawson W, et al. Prolonged exposure to melatonin leads to time-dependent sensitization of adenylate cyclase and down-regulates melatonin receptors in pars tuberalis cells from ovine pituitary. Endocrinology. 1993;132(1):285–292.
   PubMed Web of Science ®Google Scholar
• Hazlerigg DG, Hastings MH, Morgan PJ. The recovery of ovine pars tuberalis cells from melatonin-induced sensitization is a slow, protein synthesis-dependent phenomenon. J Endocrinol. 1994;142(1):127–138.
   PubMed Web of Science ®Google Scholar
• Costes S, Boss M, Thomas AP, et al. Activation of melatonin signaling promotes beta-cell survival and function. Mol Endocrinol. 2015;29(5):682–692.
   PubMedGoogle Scholar
• Kemp DM, Ubeda M, Habener JF. Identification and functional characterization of melatonin Mel 1a receptors in pancreatic beta cells: potential role in incretin-mediated cell function by sensitization of cAMP signaling. Mol Cell Endocrinol. 2002;191(2):157–166.
   PubMed Web of Science ®Google Scholar
• Motta-Teixeira LC, Machado-Nils AV, Battagello DS, et al. The absence of maternal pineal melatonin rhythm during pregnancy and lactation impairs offspring physical growth, neurodevelopment, and behavior. Horm Behav. 2018;105:146–156.
   PubMed Web of Science ®Google Scholar
• Torres-Farfan C, Rocco V, Monso C, et al. Maternal melatonin effects on clock gene expression in a nonhuman primate fetus. Endocrinology. 2006;147(10):4618–4626.
   PubMed Web of Science ®Google Scholar
• Seron-Ferre M, Torres-Farfan C, Forcelledo ML, et al. The development of circadian rhythms in the fetus and neonate. Semin Perinatol. 2001;25(6):363–370.
   PubMed Web of Science ®Google Scholar
• Weaver DR, Keohan JT, Reppert SM. Definition of a prenatal sensitive period for maternal-fetal communication of day length. Am J Physiol. 1987;253(6 Pt 1):E701–4.
   PubMed Web of Science ®Google Scholar
• Weaver DR, Reppert SM. Maternal melatonin communicates daylength to the fetus in Djungarian hamsters. Endocrinology. 1986;119(6):2861–2863.
   PubMed Web of Science ®Google Scholar
• Ferreira DS, Amaral FG, Mesquita CC, et al. Maternal melatonin programs the daily pattern of energy metabolism in adult offspring. PLoS One. 2012;7(6):e38795.
   PubMed Web of Science ®Google Scholar
• Tain YL, Huang LT, Chan JY. Transcriptional regulation of programmed hypertension by melatonin: an epigenetic perspective. Int J Mol Sci. 2014;15(10):18484–18495.
   PubMed Web of Science ®Google Scholar
• Anhe GF, Caperuto LC, Pereira-Da-Silva M, et al. In vivo activation of insulin receptor tyrosine kinase by melatonin in the rat hypothalamus. J Neurochem. 2004;90(3):559–566.
   PubMed Web of Science ®Google Scholar
• Csaba G, Barath P. Are Langerhan’s islets influenced by the pineal body? Experientia. 1971;27(8):962.
   PubMedGoogle Scholar
• Das UN. A defect in the activity of Delta6 and Delta5 desaturases may be a factor predisposing to the development of insulin resistance syndrome. Prostaglandins Leukot Essent Fatty Acids. 2005;72(5):343–350.
   PubMed Web of Science ®Google Scholar
• Diaz B, Blazquez E. Effect of pinealectomy on plasma glucose, insulin and glucagon levels in the rat. Horm Metab Res. 1986;18(4):225–229.
   PubMed Web of Science ®Google Scholar
• Ghosh G, De K, Maity S, et al. Melatonin protects against oxidative damage and restores expression of GLUT4 gene in the hyperthyroid rat heart. J Pineal Res. 2007;42(1):71–82.
   PubMed Web of Science ®Google Scholar
• Ha E, Yim SV, Chung JH, et al. Melatonin stimulates glucose transport via insulin receptor substrate-1/phosphatidylinositol 3-kinase pathway in C2C12 murine skeletal muscle cells. J Pineal Res. 2006;41(1):67–72.
   PubMed Web of Science ®Google Scholar
• Lima FB, Machado UF, Bartol I, et al. Pinealectomy causes glucose intolerance and decreases adipose cell responsiveness to insulin in rats. Am J Physiol. 1998;275(6 Pt 1):E934–41.
   PubMedGoogle Scholar
• Mellado C, Rodriguez V, de Diego JG, et al. Effect of pinealectomy and of diabetes on liver insulin and glucagon receptor concentrations in the rat. J Pineal Res. 1989;6(4):295–306.
   PubMed Web of Science ®Google Scholar
• Milcu I, Nanu L, Marcean R, et al. the Effect of Epiphysectomy on the Metabolism of Carbohydrates. Studies with Rats. Stud Cercet Endocrinol. 1965;16:17–23.
   PubMedGoogle Scholar
• Picinato MC, Hirata AE, Cipolla-Neto J, et al. Activation of insulin and IGF-1 signaling pathways by melatonin through MT1 receptor in isolated rat pancreatic islets. J Pineal Res. 2008;44(1):88–94.
   PubMed Web of Science ®Google Scholar
• Rodriguez V, Mellado C, Alvarez E, et al. Effect of pinealectomy on liver insulin and glucagon receptor concentrations in the rat. J Pineal Res. 1989;6(1):77–88.
   PubMed Web of Science ®Google Scholar
• Seraphim PM, Bartol L, Cipolla-Neto J, et al. Quantification of GLUT4 transporter in insulin-sensitive tissues from pinealectomized rats. In: Webb SM, Puig-Domingo M, Moller M, editors. Pineal Update: from Molecular Mechanisms to Clinical Implications. Westbury: PJD Publications Ltd; 1997. p. 99–106.
   Google Scholar
• Srivastava RK, Krishna A. Melatonin modulates glucose homeostasis during winter dormancy in a vespertilionid bat, Scotophilus heathi. Comp Biochem Physiol A Mol Integr Physiol. 2010;155(3):392–400.
   PubMed Web of Science ®Google Scholar
• Zanquetta MM, Seraphim PM, Sumida DH, et al. Calorie restriction reduces pinealectomy-induced insulin resistance by improving GLUT4 gene expression and its translocation to the plasma membrane. J Pineal Res. 2003;35(3):141–148.
   PubMed Web of Science ®Google Scholar
• Nogueira TC, Lellis-Santos C, Jesus DS, et al. Absence of melatonin induces night-time hepatic insulin resistance and increased gluconeogenesis due to stimulation of nocturnal unfolded protein response. Endocrinology. 2011;152(4):1253–1263.
   PubMed Web of Science ®Google Scholar
• Owino S, Sanchez-Bretano A, Tchio C, et al. Nocturnal activation of melatonin receptor type 1 signaling modulates diurnal insulin sensitivity via regulation of PI3K activity. J Pineal Res. 2018;64(3). doi:10.1111/jpi.12462.
   PubMed Web of Science ®Google Scholar
• Cagnacci A, Arangino S, Renzi A, et al. Influence of melatonin administration on glucose tolerance and insulin sensitivity of postmenopausal women. Clin Endocrinol (Oxf). 2001;54(3):339–346.
   PubMed Web of Science ®Google Scholar
• Rubio-Sastre P, Scheer FA, Gomez-Abellan P, et al. Acute melatonin administration in humans impairs glucose tolerance in both the morning and evening. Sleep. 2014;37(10):1715–1719.
   PubMed Web of Science ®Google Scholar
• Lucassen EA, Rother KI, Cizza G. Interacting epidemics? Sleep curtailment, insulin resistance, and obesity. Ann N Y Acad Sci. 2012;1264:110–134.
   PubMed Web of Science ®Google Scholar
• McMullan CJ, Curhan GC, Schernhammer ES, et al. Association of nocturnal melatonin secretion with insulin resistance in nondiabetic young women. Am J Epidemiol. 2013;178(2):231–238.
   PubMed Web of Science ®Google Scholar
• McMullan CJ, Schernhammer ES, Rimm EB, et al. Melatonin secretion and the incidence of type 2 diabetes. JAMA. 2013;309(13):1388–1396.
   PubMed Web of Science ®Google Scholar
• Reutrakul S, Siwasaranond N, Nimitphong H, et al. Associations between nocturnal urinary 6-sulfatoxymelatonin, obstructive sleep apnea severity and glycemic control in type 2 diabetes. Chronobiol Int. 2017;34(3):382–392.
   PubMed Web of Science ®Google Scholar
• Shimada M, Seki H, Samejima M, et al. Salivary melatonin levels and sleep-wake rhythms in pregnant women with hypertensive and glucose metabolic disorders: A prospective analysis. Biosci Trends. 2016;10(1):34–41.
   PubMed Web of Science ®Google Scholar
• Zemlianitsyna O, Polozova L, Karachentsev I, et al. Features of Excretion of Melatonin in Urine in Patients with Type 2 Diabetes Mellitus and Non-Alcoholic Fatty Liver Disease with Manifestations of Fibrosis and Its Relationship with Certain Metabolic and Immunological Indicators. Georgian Med News. 2018;274:103–107.
   Google Scholar
• Gil-Lozano M, Hunter PM, Behan LA, et al. Short-term sleep deprivation with nocturnal light exposure alters time-dependent glucagon-like peptide-1 and insulin secretion in male volunteers. Am J Physiol Endocrinol Metab. 2016;310(1):E41–50.
   PubMed Web of Science ®Google Scholar
• de Luis DA, Izaola O, Primo D, et al. Association of the rs10830963 polymorphism in melatonin receptor type 1B (MTNR1B) with metabolic response after weight loss secondary to a hypocaloric diet based in Mediterranean style. Clin Nutr. 2018;37(5):1563–1568.
   PubMed Web of Science ®Google Scholar
• Dehdashtian E, Mehrzadi S, Yousefi B, et al. Diabetic retinopathy pathogenesis and the ameliorating effects of melatonin; involvement of autophagy, inflammation and oxidative stress. Life Sci. 2018;193:20–33.
   PubMed Web of Science ®Google Scholar
• Kim JY, Cheong HS, Park BL, et al. Melatonin receptor 1 B polymorphisms associated with the risk of gestational diabetes mellitus. BMC Med Genet. 2011;12:82.
   PubMed Web of Science ®Google Scholar
• Langenberg C, Pascoe L, Mari A, et al. Common genetic variation in the melatonin receptor 1B gene (MTNR1B) is associated with decreased early-phase insulin response. Diabetologia. 2009;52(8):1537–1542.
   PubMed Web of Science ®Google Scholar
• Li C, Qiao B, Zhan Y, et al. Association between genetic variations in MTNR1A and MTNR1B genes and gestational diabetes mellitus in Han Chinese women. Gynecol Obstet Invest. 2013;76(4):221–227.
   PubMed Web of Science ®Google Scholar
• Li C, Zhou Y, Qiao B, et al. Association Between a Melatonin Receptor 1B Genetic Polymorphism and Its Protein Expression in Gestational Diabetes Mellitus. Reprod Sci. 2018. DOI: 10.1177/1933719118765983.
   Web of Science ®Google Scholar
• Liu Q, Huang Z, Li H, et al. Relationship between melatonin receptor 1B (rs10830963 and rs1387153) with gestational diabetes mellitus: a case-control study and meta-analysis. Arch Gynecol Obstet. 2016;294(1):55–61.
   PubMed Web of Science ®Google Scholar
• Lu XL, Yao XY, Liu XL, et al. Melatonin receptor 1B gene polymorphism rs10830963 and gestational diabetes mellitus among a Chinese population - a meta-analysis of association studies. Endokrynol Pol. 2017;68(5):550–560.
   PubMed Web of Science ®Google Scholar
• Salman M, Dasgupta S, Cholendra A, et al. MTNR1B gene polymorphisms and susceptibility to Type 2 Diabetes: A pilot study in South Indians. Gene. 2015;566(2):189–193.
   PubMed Web of Science ®Google Scholar
• Vejrazkova D, Lukasova P, Vankova M, et al. MTNR1B Genetic Variability Is Associated with Gestational Diabetes in Czech Women. Int J Endocrinol. 2014;2014:508923.
   PubMed Web of Science ®Google Scholar
• Wang H, Liu L, Zhao J, et al. Large scale meta-analyses of fasting plasma glucose raising variants in GCK, GCKR, MTNR1B and G6PC2 and their impacts on type 2 diabetes mellitus risk. PLoS One. 2013;8(6):e67665.
   PubMed Web of Science ®Google Scholar
• Zhan Y, Li C, Gao Q, et al. Association between the rs4753426 polymorphism in MTNR1B with fasting plasma glucose level and pancreatic beta-cell function in gestational diabetes mellitus. Genet Mol Res. 2015;14(3):8778–8785.
   PubMed Web of Science ®Google Scholar
• Bonnefond A, Froguel P. The case for too little melatonin signalling in increased diabetes risk. Diabetologia. 2017;60(5):823–825.
   PubMed Web of Science ®Google Scholar
• Karamitri A, Jockers R. Melatonin in type 2 diabetes mellitus and obesity. Nat Rev Endocrinol. 2019;15(2):105–125.
   PubMed Web of Science ®Google Scholar
• Ghaderi A, Banafshe HR, Mirhosseini N, et al. The effects of melatonin supplementation on mental health, metabolic and genetic profiles in patients under methadone maintenance treatment. Addict Biol. 2018;24:754-764.
   PubMed Web of Science ®Google Scholar
• Gonciarz M, Bielanski W, Partyka R, et al. Plasma insulin, leptin, adiponectin, resistin, ghrelin, and melatonin in nonalcoholic steatohepatitis patients treated with melatonin. J Pineal Res. 2013;54(2):154–161.
   PubMed Web of Science ®Google Scholar
• Halpern B, Mancini MC, Bueno C, et al. Melatonin Increases Brown Adipose Tissue Volume and Activity in Melatonin Deficient Patients: a Proof-of-Concept Study. Diabetes. 2019.
   PubMed Web of Science ®Google Scholar
• Raygan F, Ostadmohammadi V, Bahmani F, et al. Melatonin administration lowers biomarkers of oxidative stress and cardio-metabolic risk in type 2 diabetic patients with coronary heart disease: A randomized, double-blind, placebo-controlled trial. Clin Nutr. 2019;38(1):191–196.
   PubMed Web of Science ®Google Scholar
• Sharma S, Singh H, Ahmad N, et al. The role of melatonin in diabetes: therapeutic implications. Arch Endocrinol Metab. 2015;59(5):391–399.
   PubMed Web of Science ®Google Scholar
• Sun H, Wang X, Chen J, et al. Melatonin Treatment Improves Insulin Resistance and Pigmentation in Obese Patients with Acanthosis Nigricans. Int J Endocrinol. 2018;2018:2304746.
   PubMed Web of Science ®Google Scholar
• Tsunoda T, Yamada M, Akiyama T, et al. The Effects of Ramelteon on Glucose Metabolism and Sleep Quality in Type 2 Diabetic Patients With Insomnia: A Pilot Prospective Randomized Controlled Trial. J Clin Med Res. 2016;8(12):878–887.
   PubMedGoogle Scholar
• Buonfiglio D, Parthimos R, Dantas R, et al. Melatonin Absence Leads to Long-Term Leptin Resistance and Overweight in Rats. Front Endocrinol (Lausanne). 2018;9:122.
   PubMed Web of Science ®Google Scholar
• Piccinetti CC, Migliarini B, Olivotto I, et al. Appetite regulation: the central role of melatonin in Danio rerio. Horm Behav. 2010;58(5):780–785.
   PubMed Web of Science ®Google Scholar
• Alonso-Vale MI, Andreotti S, Borges-Silva C, et al. Intermittent and rhythmic exposure to melatonin in primary cultured adipocytes enhances the insulin and dexamethasone effects on leptin expression. J Pineal Res. 2006;41(1):28–34.
   PubMed Web of Science ®Google Scholar
• Alonso-Vale MI, Andreotti S, Peres SB, et al. Melatonin enhances leptin expression by rat adipocytes in the presence of insulin. Am J Physiol Endocrinol Metab. 2005;288(4):E805–12.
   PubMed Web of Science ®Google Scholar
• Buonfiglio D, Tchio C, Furigo I, et al. Removing Melatonin Receptor Type 1 Signaling Leads to Selective Leptin Resistance in The Arcuate Nucleus. J Pineal Res. 2019;e12580.
   PubMed Web of Science ®Google Scholar
• Bahr I, Muhlbauer E, Schucht H, et al. Melatonin stimulates glucagon secretion in vitro and in vivo. J Pineal Res. 2011;50(3):336–344.
   PubMed Web of Science ®Google Scholar
• Picinato MC, Haber EP, Carpinelli AR, et al. Daily rhythm of glucose-induced insulin secretion by isolated islets from intact and pinealectomized rat. J Pineal Res. 2002;33(3):172–177.
   PubMed Web of Science ®Google Scholar
• Picinato MC, Haber EP, Cipolla-Neto J, et al. Melatonin inhibits insulin secretion and decreases PKA levels without interfering with glucose metabolism in rat pancreatic islets. J Pineal Res. 2002;33(3):156–160.
   PubMed Web of Science ®Google Scholar
• Zibolka J, Muhlbauer E, Peschke E. Melatonin influences somatostatin secretion from human pancreatic delta-cells via MT1 and MT2 receptors. J Pineal Res. 2015;58(2):198–209.
   PubMed Web of Science ®Google Scholar
• Zanuto R, Siqueira-Filho MA, Caperuto LC, et al. Melatonin improves insulin sensitivity independently of weight loss in old obese rats. J Pineal Res. 2013;55(2):156–165.
   PubMed Web of Science ®Google Scholar
• Borges-Silva C, Takada J, Alonso-Vale MI, et al. Pinealectomy reduces hepatic and muscular glycogen content and attenuates aerobic power adaptability in trained rats. J Pineal Res. 2007;43(1):96–103.
   PubMed Web of Science ®Google Scholar
• de Souza CAP, Gallo CC, de Camargo LS, et al. Melatonin multiple effects on brown adipose tissue molecular machinery. J Pineal Res. 2019;66(2):e12549.
   PubMed Web of Science ®Google Scholar
• Tan DX, Manchester LC, Fuentes-Broto L, et al. Significance and application of melatonin in the regulation of brown adipose tissue metabolism: relation to human obesity. Obes Rev. 2011;12(3):167–188.
   PubMed Web of Science ®Google Scholar
• Jimenez-Aranda A, Fernandez-Vazquez G, Campos D, et al. Melatonin induces browning of inguinal white adipose tissue in Zucker diabetic fatty rats. J Pineal Res. 2013;55(4):416–423.
   PubMed Web of Science ®Google Scholar
• Amstrup AK, Sikjaer T, Pedersen SB, et al. Reduced fat mass and increased lean mass in response to 1 year of melatonin treatment in postmenopausal women: A randomized placebo-controlled trial. Clin Endocrinol (Oxf). 2016;84(3):342–347.
   PubMed Web of Science ®Google Scholar
• Goncalves AL, Martini Ferreira A, Ribeiro RT, et al. Randomised clinical trial comparing melatonin 3 mg, amitriptyline 25 mg and placebo for migraine prevention. J Neurol Neurosurg Psychiatry. 2016;87(10):1127–1132.
   PubMed Web of Science ®Google Scholar
• Mostafavi SA, Solhi M, Mohammadi MR, et al. Melatonin for Reducing Weight Gain Following Administration of Atypical Antipsychotic Olanzapine for Adolescents with Bipolar Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial. J Child Adolesc Psychopharmacol. 2017;27(5):440–444.
   PubMed Web of Science ®Google Scholar
• Erren TC, Reiter RJ. Defining chronodisruption. J Pineal Res. 2009;46(3):245–247.
   PubMed Web of Science ®Google Scholar
• Buxton OM, Cain SW, O’Connor SP, et al. Adverse metabolic consequences in humans of prolonged sleep restriction combined with circadian disruption. Sci Transl Med. 2012;4(129):129ra43.
   PubMed Web of Science ®Google Scholar
• Patel SR, Hu FB. Short sleep duration and weight gain: a systematic review. Obesity (Silver Spring). 2008;16(3):643–653.
   PubMed Web of Science ®Google Scholar
• Van Cauter E, Knutson KL. Sleep and the epidemic of obesity in children and adults. Eur J Endocrinol. 2008;159(Suppl 1):S59–66.
   PubMed Web of Science ®Google Scholar
• Auld F, Maschauer EL, Morrison I, et al. Evidence for the efficacy of melatonin in the treatment of primary adult sleep disorders. Sleep Med Rev. 2017;34:10–22.
   PubMed Web of Science ®Google Scholar
• Ferracioli-Oda E, Qawasmi A, Bloch MH. Meta-analysis: melatonin for the treatment of primary sleep disorders. PLoS One. 2013;8(5):e63773.
   PubMed Web of Science ®Google Scholar
• Laudon M, Frydman-Marom A. Therapeutic effects of melatonin receptor agonists on sleep and comorbid disorders. Int J Mol Sci. 2014;15(9):15924–15950.
   PubMed Web of Science ®Google Scholar
• Xie Z, Chen F, Li WA, et al. A review of sleep disorders and melatonin. Neurol Res. 2017;39(6):559–565.
   PubMed Web of Science ®Google Scholar
• Amani R, Gill T. Shiftworking, nutrition and obesity: implications for workforce health- a systematic review. Asia Pac J Clin Nutr. 2013;22(4):505–515.
   PubMed Web of Science ®Google Scholar
• Chaput JP, Despres JP, Bouchard C, et al. The association between sleep duration and weight gain in adults: a 6-year prospective study from the Quebec Family Study. Sleep. 2008;31(4):517–523.
   PubMed Web of Science ®Google Scholar
• Mohammadi-Sartang M, Ghorbani M, Mazloom Z. Effects of melatonin supplementation on blood lipid concentrations: A systematic review and meta-analysis of randomized controlled trials. Clin Nutr. 2018;37(6 Pt A):1943–1954.
   PubMed Web of Science ®Google Scholar
• Lemoine P, Nir T, Laudon M, et al. Prolonged-release melatonin improves sleep quality and morning alertness in insomnia patients aged 55 years and older and has no withdrawal effects. J Sleep Res. 2007;16(4):372–380.
   PubMed Web of Science ®Google Scholar
• Lyseng-Williamson KA. Melatonin prolonged release: in the treatment of insomnia in patients aged >/=55 years. Drugs Aging. 2012;29(11):911–923.
   PubMed Web of Science ®Google Scholar